Cite
Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma
MLA
Marius Ilié, et al. “Association of TRF2 Expression and Myeloid-Derived Suppressor Cells Infiltration with Clinical Outcome of Patients with Cutaneous Melanoma.” OncoImmunology, vol. 10, no. 1, Jan. 2021. EBSCOhost, https://doi.org/10.1080/2162402X.2021.1901446.
APA
Marius Ilié, Elisabeth Lantéri, Emmanuel Chamorey, Brice Thamphya, Marame Hamila, Henri Montaudié, Alexandra Picard-Gauci, Sophie Gardrat, Thierry Passeron, Sandra Lassalle, Elodie Long-Mira, Julien Cherfils-Vicini, Eric Gilson, Véronique Hofman, & Paul Hofman. (2021). Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma. OncoImmunology, 10(1). https://doi.org/10.1080/2162402X.2021.1901446
Chicago
Marius Ilié, Elisabeth Lantéri, Emmanuel Chamorey, Brice Thamphya, Marame Hamila, Henri Montaudié, Alexandra Picard-Gauci, et al. 2021. “Association of TRF2 Expression and Myeloid-Derived Suppressor Cells Infiltration with Clinical Outcome of Patients with Cutaneous Melanoma.” OncoImmunology 10 (1). doi:10.1080/2162402X.2021.1901446.